GROMBIŘÍKOVÁ, Hana, Viktor BÍLY, Přemysl SOUČEK, Michal KRAMÁREK, Roman HAKL, Lucie BALLONOVÁ, Barbora RAVCUKOVA, Dita RICNA, Karolína KOŽENÁ, Lucie KRATOCHVÍLOVÁ, Marta SOBOTKOVA, Radana ZACHOVA, Pavel KUKLÍNEK, Pavlina KRALICKOVA, Irena KRCMOVA, Jana HANZLIKOVA, Martina VACHOVA, Olga KRYSTUFKOVA, Eva DANKOVA, Milos JESENAK, Martina NOVACKOVA, Michal SVOBODA, Jiří LITZMAN and Tomáš FREIBERGER. Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort. Journal of Clinical Immunology. NEW YORK: SPRINGER, 2023, vol. 43, No 8, p. 1974-1991. ISSN 0271-9142. Available from: https://dx.doi.org/10.1007/s10875-023-01565-w.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort
Authors GROMBIŘÍKOVÁ, Hana (203 Czech Republic, belonging to the institution), Viktor BÍLY (703 Slovakia, belonging to the institution), Přemysl SOUČEK (203 Czech Republic, belonging to the institution), Michal KRAMÁREK (703 Slovakia, belonging to the institution), Roman HAKL (203 Czech Republic, belonging to the institution), Lucie BALLONOVÁ (203 Czech Republic, belonging to the institution), Barbora RAVCUKOVA, Dita RICNA, Karolína KOŽENÁ (203 Czech Republic, belonging to the institution), Lucie KRATOCHVÍLOVÁ (203 Czech Republic), Marta SOBOTKOVA (203 Czech Republic), Radana ZACHOVA (203 Czech Republic), Pavel KUKLÍNEK (203 Czech Republic, belonging to the institution), Pavlina KRALICKOVA (203 Czech Republic), Irena KRCMOVA (203 Czech Republic), Jana HANZLIKOVA (203 Czech Republic), Martina VACHOVA (203 Czech Republic), Olga KRYSTUFKOVA (203 Czech Republic), Eva DANKOVA (203 Czech Republic), Milos JESENAK (703 Slovakia), Martina NOVACKOVA (203 Czech Republic), Michal SVOBODA (203 Czech Republic), Jiří LITZMAN (203 Czech Republic, belonging to the institution) and Tomáš FREIBERGER (203 Czech Republic, belonging to the institution).
Edition Journal of Clinical Immunology, NEW YORK, SPRINGER, 2023, 0271-9142.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 9.100 in 2022
RIV identification code RIV/00216224:14110/23:00132410
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s10875-023-01565-w
UT WoS 001063524100001
Keywords in English HAE; C1-INH-HAE; hereditary angioedema; SERPING1; splicing genotype–phenotype relationship; time to diagnosis
Tags 14110114, 14110911, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 8/7/2024 13:57.
Abstract
Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare and life-threatening condition characterized by recurrent localized edema. We conducted a systematic screening of SERPING1 defects in a cohort of 207 Czech patients from 85 families with C1-INH-HAE. Our workflow involved a combined strategy of sequencing extended to UTR and deep intronic regions, advanced in silico prediction tools, and mRNA-based functional assays. This approach allowed us to detect a causal variant in all families except one and to identify a total of 56 different variants, including 5 novel variants that are likely to be causal. We further investigated the functional impact of two splicing variants, namely c.550 + 3A > C and c.686-7C > G using minigene assays and RT-PCR mRNA analysis. Notably, our cohort showed a considerably higher proportion of detected splicing variants compared to other central European populations and the LOVD database. Moreover, our findings revealed a significant association between HAE type 1 missense variants and a delayed HAE onset when compared to null variants. We also observed a significant correlation between the presence of the SERPING1 variant c.-21 T > C in the trans position to causal variants and the frequency of attacks per year, disease onset, as well as Clinical severity score. Overall, our study provides new insights into the genetic landscape of C1-INH-HAE in the Czech population, including the identification of novel variants and a better understanding of genotype–phenotype correlations. Our findings also highlight the importance of comprehensive screening strategies and functional analyses in improving the C1-INH-HAE diagnosis and management.
Links
MUNI/A/1098/2022, interní kód MUName: Nespecifická imunita u chorob imunitního systému
Investor: Masaryk University, Non-specific immunity in immune system diseases
NV18-05-00330, research and development projectName: Genetická determinace závažnosti otoků podmíněných bradykininem u pacientů s hereditárním angioedémem
Investor: Ministry of Health of the CR, Genetic determination of bradykinin-mediated angioedema severity in patients with hereditary angioedema
PrintDisplayed: 19/7/2024 15:20